GP-1683

N/A

Report date: 2022/08/23 20:00:44
NME

Base Information

Drug NameGP-1683
Drug Alias NameGP-683
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine kinase inhibitors
TargetsAdenosine kinase
Therapy Area/IndicationsSeizuresStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSICOR Spa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMetabasis Therapeutics IncSICOR Spa
Active IndicationsN/A
Inactive IndicationsSeizuresStroke

Other Information

ATC CodeN/A
Related LinksN/A